| Literature DB >> 35352249 |
G B Kolyvanov1, P O Bochkov1, A A Litvin2, R V Shevchenko1, A L Podol'ko1, O Yu Kravtsova1, K N Kolyasnikova1, V P Zherdev1.
Abstract
Metabolism of a new neuroprotector GZK-111 (N-phenylacetylglycyl-L-proline ethyl ester) in rat blood plasma was studied by HPLC-mass spectrometry. Four biotransformation products were identified. It is concluded that the main ways of GZK-111 biotransformation are hydrolysis of the ester bond by esterases followed by degradation of the resulting metabolite, as well as reactions leading to the formation of phenylacetic acid and cycloprolylglycine that exhibits neuropsychotropic activity.Entities:
Keywords: GZK-111; HPLC-mass spectrometry; metabolism; neuroprotector
Mesh：
Substances：
Year: 2022 PMID： 35352249 DOI： 10.1007/s10517-022-05440-3
Source DB: PubMed Journal: Bull Exp Biol Med ISSN： 0007-4888 Impact factor: 0.804